MedTrace Logo

Metacognitive Therapy for Comorbid Insomnia

NCT00235365 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2012-11-22

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of meta-cognitive therapy for insomnia.

Conditions

  • Secondary Insomnia

Interventions

BEHAVIORAL

meta-cognitive therapy

Meta-cognitive therapy

OTHER

waiting list

waiting list control

Sponsors & Collaborators

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Gunnar Morken, PhD MD · Norwegian University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-01-31
Completion
2011-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00235365 on ClinicalTrials.gov